Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-03-24
DOI
10.3389/fnagi.2014.00047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
- (2018) Maria Bjerke et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers and Memory Present Distinct Associations along the Continuum from Healthy Subjects to AD Patients
- (2018) Lorena Rami et al. JOURNAL OF ALZHEIMERS DISEASE
- Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease
- (2018) Lisa M. Bloudek et al. JOURNAL OF ALZHEIMERS DISEASE
- Value of Diagnostic tests to Predict Conversion to Alzheimer's Disease in Young and Old Patients with Amnestic Mild Cognitive Impairment
- (2018) Ben Schmand et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
- (2018) Henrik Zetterberg et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Two Analytical Platforms for the Clinical Qualification of Alzheimer's Disease Biomarkers in Pathologically-Confirmed Dementia
- (2018) Nathalie Le Bastard et al. JOURNAL OF ALZHEIMERS DISEASE
- Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
- (2018) Lucilla Parnetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of the 2008–2012 French Alzheimer Plan on the Use of Cerebrospinal Fluid Biomarkers in Research Memory Center: The PLM Study
- (2018) Audrey Gabelle et al. JOURNAL OF ALZHEIMERS DISEASE
- Combination of 18F-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients
- (2018) IL Han Choo et al. JOURNAL OF ALZHEIMERS DISEASE
- The AD-CSF-Index Discriminates Alzheimer's Disease Patients from Healthy Controls: A Validation Study
- (2018) Jose L. Molinuevo et al. JOURNAL OF ALZHEIMERS DISEASE
- Disease State Fingerprint in Frontotemporal Degeneration with Reference to Alzheimer's Disease and Mild Cognitive Impairment
- (2018) Miguel Ángel Muñoz-Ruiz et al. JOURNAL OF ALZHEIMERS DISEASE
- Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease
- (2017) Miroslaw Brys et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
- (2013) Shannon L. Risacher et al. Annual Review of Clinical Psychology
- A New Decision Tree Combining Abeta 1-42 and p-Tau Levels in Alzheimer's Diagnosis
- (2013) Stephanie Bombois et al. Current Alzheimer Research
- Cerebrospinal fluid biomarkers for pathological processes in Alzheimerʼs disease
- (2013) Christoffer Rosén et al. CURRENT OPINION IN PSYCHIATRY
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Comparación de la capacidad diagnóstica precoz de los biomarcadores de la enfermedad de Alzheimer en resonancia magnética cerebral y líquido cefalorraquídeo
- (2013) J.A. Monge Argilés et al. NEUROLOGIA
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Preclinical AD predicts decline in memory and executive functions in subjective complaints
- (2013) A. C. van Harten et al. NEUROLOGY
- Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
- (2013) S. J. B. Vos et al. NEUROLOGY
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
- (2013) A. Prestia et al. NEUROLOGY
- Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
- (2013) Yawu Liu et al. PLoS One
- BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease
- (2013) Christian Gaser et al. PLoS One
- Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
- (2013) Erika J. Lampert et al. PLoS One
- Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With β-Amyloidosis
- (2013) David S. Knopman et al. JAMA Neurology
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
- (2012) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Apolipoprotein Eε4 Does Not Modulate Amyloid-β–Associated Neurodegeneration in Preclinical Alzheimer Disease
- (2012) R.S. Desikan et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Comparison of Cerebrospinal Fluid Levels of Tau and Aβ 1-42 in Alzheimer Disease and Frontotemporal Degeneration Using 2 Analytical Platforms
- (2012) David J. Irwin et al. ARCHIVES OF NEUROLOGY
- Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease
- (2012) François Mouton-Liger et al. BIOLOGICAL PSYCHIATRY
- The development of effective biomarkers for Alzheimer's disease: a review
- (2012) Mark S. Henry et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
- (2012) Mirko Bibl et al. JOURNAL OF NEURAL TRANSMISSION
- Supporting evidence for using biomarkers in the diagnosis of MCI due to AD
- (2012) Samantha Galluzzi et al. JOURNAL OF NEUROLOGY
- Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
- (2012) Stephanie Vos et al. NEUROBIOLOGY OF AGING
- Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion
- (2012) Eric Westman et al. NEUROIMAGE
- Age and diagnostic performance of Alzheimer disease CSF biomarkers
- (2012) N. Mattsson et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
- (2012) Dominic Holland et al. PLoS One
- CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade
- (2012) Xianfeng Yang et al. PLoS One
- Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
- (2012) Jennifer L. Shaffer et al. RADIOLOGY
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- (2011) Argonde C. van Harten et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment
- (2011) C. Eckerström et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- CSF biomarkers for Alzheimer's disease: current utility and potential future use
- (2011) David M. Holtzman NEUROBIOLOGY OF AGING
- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations
- (2011) Juan Fortea et al. Neurodegenerative Diseases
- CSF metabolites in the differential diagnosis of Alzheimer’s disease from frontal variant of frontotemporal dementia
- (2011) Francesca de Rino et al. NEUROLOGICAL SCIENCES
- Predicting MCI outcome with clinically available MRI and CSF biomarkers
- (2011) D. Heister et al. NEUROLOGY
- Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors
- (2011) Yue Cui et al. PLoS One
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses
- (2010) Hans Brunnström et al. Alzheimers & Dementia
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
- (2010) K.B. Walhovd et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
- (2010) C. R. Jack et al. BRAIN
- Development of an Ultra-Rapid Diagnostic Method Based on Heart-Type Fatty Acid Binding Protein Levels in the CSF of CJD Patients
- (2010) Yuki Matsui et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
- (2010) P.E. Spies et al. Current Alzheimer Research
- Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis
- (2010) Celeste A de Jager et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline
- (2010) J. Nettiksimmons et al. NEUROBIOLOGY OF AGING
- Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification
- (2010) Christos Davatzikos et al. NEUROBIOLOGY OF AGING
- Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
- (2010) Michael Ewers et al. NEUROBIOLOGY OF AGING
- Serial MRI and CSF biomarkers in normal aging, MCI, and AD
- (2010) P. Vemuri et al. NEUROLOGY
- Comparing predictors of conversion and decline in mild cognitive impairment
- (2010) S. M. Landau et al. NEUROLOGY
- Relationship between atrophy and β-amyloid deposition in Alzheimer's disease
- (2009) Gaël Chételat et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Biological markers of amyloid β-related mechanisms in Alzheimer's disease
- (2009) Harald Hampel et al. EXPERIMENTAL NEUROLOGY
- Use of Alzheimer Disease Biomarkers
- (2009) Ronald C. Petersen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies
- (2009) A J Mitchell JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change
- (2009) P. Vemuri et al. NEUROLOGY
- Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease
- (2009) B. Schmand et al. PSYCHOLOGICAL MEDICINE
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
- (2008) Christopher D. Aluise et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
- Biochemical markers in persons with preclinical familial Alzheimer disease
- (2008) J. M. Ringman et al. NEUROLOGY
- Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
- (2008) Breno S. O. Diniz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease
- (2007) Harald Hampel et al. Alzheimers & Dementia
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started